Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Mar;62(3):551–561. doi: 10.1086/301755

Genotype-phenotype relationships in ataxia-telangiectasia and variants.

S Gilad 1, L Chessa 1, R Khosravi 1, P Russell 1, Y Galanty 1, M Piane 1, R A Gatti 1, T J Jorgensen 1, Y Shiloh 1, A Bar-Shira 1
PMCID: PMC1376949  PMID: 9497252

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, radiosensitivity, and cancer predisposition. A-T cells are sensitive to ionizing radiation and radiomimetic chemicals and fail to activate cell-cycle checkpoints after treatment with these agents. The responsible gene, ATM, encodes a large protein kinase with a phosphatidylinositol 3-kinase-like domain. The typical A-T phenotype is caused, in most cases, by null ATM alleles that truncate or severely destabilize the ATM protein. Rare patients with milder manifestations of the clinical or cellular characteristics of the disease have been reported and have been designated "A-T variants." A special variant form of A-T is A-TFresno, which combines a typical A-T phenotype with microcephaly and mental retardation. The possible association of these syndromes with ATM is both important for understanding their molecular basis and essential for counseling and diagnostic purposes. We quantified ATM-protein levels in six A-T variants, and we searched their ATM genes for mutations. Cell lines from these patients exhibited considerable variability in radiosensitivity while showing the typical radioresistant DNA synthesis of A-T cells. Unlike classical A-T patients, these patients exhibited 1%-17% of the normal level of ATM. The underlying ATM genotypes were either homozygous for mutations expected to produce mild phenotypes or compound heterozygotes for a mild and a severe mutation. An A-TFresno cell line was found devoid of the ATM protein and homozygous for a severe ATM mutation. We conclude that certain "A-T variant" phenotypes represent ATM mutations, including some of those without telangiectasia. Our findings extend the range of phenotypes associated with ATM mutations.

Full Text

The Full Text of this article is available as a PDF (493.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoccia A., Chessa L., Ricordy R., Tanzarella C. Modulation of radiation-induced chromosomal damage by inhibitors of DNA repair and flow cytometric analysis in ataxia telangiectasia cells with 'intermediate radiosensitivity'. Mutagenesis. 1995 Nov;10(6):523–529. doi: 10.1093/mutage/10.6.523. [DOI] [PubMed] [Google Scholar]
  2. Baumer A., Bernthaler U., Wolz W., Hoehn H., Schindler D. New mutations in the ataxia telangiectasia gene. Hum Genet. 1996 Aug;98(2):246–249. doi: 10.1007/s004390050202. [DOI] [PubMed] [Google Scholar]
  3. Beamish H., Lavin M. F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int J Radiat Biol. 1994 Feb;65(2):175–184. doi: 10.1080/09553009414550211. [DOI] [PubMed] [Google Scholar]
  4. Beamish H., Williams R., Chen P., Lavin M. F. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J Biol Chem. 1996 Aug 23;271(34):20486–20493. doi: 10.1074/jbc.271.34.20486. [DOI] [PubMed] [Google Scholar]
  5. Brown E. J., Beal P. A., Keith C. T., Chen J., Shin T. B., Schreiber S. L. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature. 1995 Oct 5;377(6548):441–446. doi: 10.1038/377441a0. [DOI] [PubMed] [Google Scholar]
  6. Brown K. D., Ziv Y., Sadanandan S. N., Chessa L., Collins F. S., Shiloh Y., Tagle D. A. The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1840–1845. doi: 10.1073/pnas.94.5.1840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bundey S. Clinical and genetic features of ataxia-telangiectasia. Int J Radiat Biol. 1994 Dec;66(6 Suppl):S23–S29. [PubMed] [Google Scholar]
  8. Byrd P. J., McConville C. M., Cooper P., Parkhill J., Stankovic T., McGuire G. M., Thick J. A., Taylor A. M. Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. Hum Mol Genet. 1996 Jan;5(1):145–149. doi: 10.1093/hmg/5.1.145. [DOI] [PubMed] [Google Scholar]
  9. Byrne E., Hallpike J. F., Manson J. I., Sutherland G. R., Thong Y. H. Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability. J Neurol Sci. 1984 Nov-Dec;66(2-3):307–317. doi: 10.1016/0022-510x(84)90019-4. [DOI] [PubMed] [Google Scholar]
  10. Chen G., Lee EYHP The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J Biol Chem. 1996 Dec 27;271(52):33693–33697. doi: 10.1074/jbc.271.52.33693. [DOI] [PubMed] [Google Scholar]
  11. Chen P. C., Lavin M. F., Kidson C., Moss D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature. 1978 Aug 3;274(5670):484–486. doi: 10.1038/274484a0. [DOI] [PubMed] [Google Scholar]
  12. Chessa L., Petrinelli P., Antonelli A., Fiorilli M., Elli R., Marcucci L., Federico A., Gandini E. Heterogeneity in ataxia-telangiectasia: classical phenotype associated with intermediate cellular radiosensitivity. Am J Med Genet. 1992 Mar 1;42(5):741–746. doi: 10.1002/ajmg.1320420524. [DOI] [PubMed] [Google Scholar]
  13. Concannon P., Gatti R. A. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum Mutat. 1997;10(2):100–107. doi: 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  14. Curry C. J., O'Lague P., Tsai J., Hutchison H. T., Jaspers N. G., Wara D., Gatti R. A., Hutchinson H. T. ATFresno: a phenotype linking ataxia-telangiectasia with the Nijmegen breakage syndrome. Am J Hum Genet. 1989 Aug;45(2):270–275. [PMC free article] [PubMed] [Google Scholar]
  15. Fiorilli M., Antonelli A., Russo G., Crescenzi M., Carbonari M., Petrinelli P. Variant of ataxia-telangiectasia with low-level radiosensitivity. Hum Genet. 1985;70(3):274–277. doi: 10.1007/BF00273456. [DOI] [PubMed] [Google Scholar]
  16. Friedman J. H., Weitberg A. Ataxia without telangiectasia. Mov Disord. 1993 Apr;8(2):223–226. doi: 10.1002/mds.870080222. [DOI] [PubMed] [Google Scholar]
  17. Gatti R. A., Berkel I., Boder E., Braedt G., Charmley P., Concannon P., Ersoy F., Foroud T., Jaspers N. G., Lange K. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 1988 Dec 8;336(6199):577–580. doi: 10.1038/336577a0. [DOI] [PubMed] [Google Scholar]
  18. Gilad S., Bar-Shira A., Harnik R., Shkedy D., Ziv Y., Khosravi R., Brown K., Vanagaite L., Xu G., Frydman M. Ataxia-telangiectasia: founder effect among north African Jews. Hum Mol Genet. 1996 Dec;5(12):2033–2037. doi: 10.1093/hmg/5.12.2033. [DOI] [PubMed] [Google Scholar]
  19. Gilad S., Khosravi R., Harnik R., Ziv Y., Shkedy D., Galanty Y., Frydman M., Levi J., Sanal O., Chessa L. Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in Israel. Hum Mutat. 1998;11(1):69–75. doi: 10.1002/(SICI)1098-1004(1998)11:1<69::AID-HUMU11>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  20. Gilad S., Khosravi R., Shkedy D., Uziel T., Ziv Y., Savitsky K., Rotman G., Smith S., Chessa L., Jorgensen T. J. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet. 1996 Apr;5(4):433–439. doi: 10.1093/hmg/5.4.433. [DOI] [PubMed] [Google Scholar]
  21. Güttler F., Guldberg P. The influence of mutations of enzyme activity and phenylalanine tolerance in phenylalanine hydroxylase deficiency. Eur J Pediatr. 1996 Jul;155 (Suppl 1):S6–10. doi: 10.1007/pl00014253. [DOI] [PubMed] [Google Scholar]
  22. Hoekstra M. F. Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family. Curr Opin Genet Dev. 1997 Apr;7(2):170–175. doi: 10.1016/s0959-437x(97)80125-6. [DOI] [PubMed] [Google Scholar]
  23. Houldsworth J., Lavin M. F. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Res. 1980 Aug 25;8(16):3709–3720. doi: 10.1093/nar/8.16.3709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jorgensen T. J., Shiloh Y. The ATM gene and the radiobiology of ataxia-telangiectasia. Int J Radiat Biol. 1996 May;69(5):527–537. doi: 10.1080/095530096145535. [DOI] [PubMed] [Google Scholar]
  25. Khanna K. K., Yan J., Watters D., Hobson K., Beamish H., Spring K., Shiloh Y., Gatti R. A., Lavin M. F. Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells. J Biol Chem. 1997 Apr 4;272(14):9489–9495. doi: 10.1074/jbc.272.14.9489. [DOI] [PubMed] [Google Scholar]
  26. Lakin N. D., Weber P., Stankovic T., Rottinghaus S. T., Taylor A. M., Jackson S. P. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene. 1996 Dec 19;13(12):2707–2716. [PubMed] [Google Scholar]
  27. Lange E., Borresen A. L., Chen X., Chessa L., Chiplunkar S., Concannon P., Dandekar S., Gerken S., Lange K., Liang T. Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am J Hum Genet. 1995 Jul;57(1):112–119. [PMC free article] [PubMed] [Google Scholar]
  28. Lanzi G., Balottin U., Franciotta D., Maserati E., Ottolini A., Pasquali F., Veggiotti P. Clinical, cytogenetic and immunological aspects in 4 cases resembling ataxia telangiectasia. Eur Neurol. 1992;32(3):121–125. doi: 10.1159/000116807. [DOI] [PubMed] [Google Scholar]
  29. Lavin M. F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol. 1997;15:177–202. doi: 10.1146/annurev.immunol.15.1.177. [DOI] [PubMed] [Google Scholar]
  30. Littlefield L. G., Colyer S. P., Joiner E. E., DuFrain R. J., Frome E., Cohen M. M. Chromosomal radiation sensitivity in ataxia telangiectasia long-term lymphoblastoid cell lines. Cytogenet Cell Genet. 1981;31(4):203–213. doi: 10.1159/000131650. [DOI] [PubMed] [Google Scholar]
  31. Maquat L. E. Defects in RNA splicing and the consequence of shortened translational reading frames. Am J Hum Genet. 1996 Aug;59(2):279–286. [PMC free article] [PubMed] [Google Scholar]
  32. Maserati E., Ottolini A., Veggiotti P., Lanzi G., Pasquali F. Ataxia-without-telangiectasia in two sisters with rearrangements of chromosomes 7 and 14. Clin Genet. 1988 Nov;34(5):283–287. doi: 10.1111/j.1399-0004.1988.tb02879.x. [DOI] [PubMed] [Google Scholar]
  33. McConville C. M., Stankovic T., Byrd P. J., McGuire G. M., Yao Q. Y., Lennox G. G., Taylor M. R. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996 Aug;59(2):320–330. [PMC free article] [PubMed] [Google Scholar]
  34. Mount S. M. A catalogue of splice junction sequences. Nucleic Acids Res. 1982 Jan 22;10(2):459–472. doi: 10.1093/nar/10.2.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Painter R. B., Young B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7315–7317. doi: 10.1073/pnas.77.12.7315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rotman G., Shiloh Y. The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress. Cancer Surv. 1997;29:285–304. [PubMed] [Google Scholar]
  37. Saar K., Chrzanowska K. H., Stumm M., Jung M., Nürnberg G., Wienker T. F., Seemanová E., Wegner R. D., Reis A., Sperling K. The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1-cM interval on chromosome 8q21. Am J Hum Genet. 1997 Mar;60(3):605–610. [PMC free article] [PubMed] [Google Scholar]
  38. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995 Jun 23;268(5218):1749–1753. doi: 10.1126/science.7792600. [DOI] [PubMed] [Google Scholar]
  39. Savitsky K., Platzer M., Uziel T., Gilad S., Sartiel A., Rosenthal A., Elroy-Stein O., Shiloh Y., Rotman G. Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression. Nucleic Acids Res. 1997 May 1;25(9):1678–1684. doi: 10.1093/nar/25.9.1678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Savitsky K., Sfez S., Tagle D. A., Ziv Y., Sartiel A., Collins F. S., Shiloh Y., Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet. 1995 Nov;4(11):2025–2032. doi: 10.1093/hmg/4.11.2025. [DOI] [PubMed] [Google Scholar]
  41. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet. 1997;31:635–662. doi: 10.1146/annurev.genet.31.1.635. [DOI] [PubMed] [Google Scholar]
  42. Shiloh Y. Ataxia-telangiectasia: closer to unraveling the mystery. Eur J Hum Genet. 1995;3(2):116–138. doi: 10.1159/000472285. [DOI] [PubMed] [Google Scholar]
  43. Shiloh Y., Rotman G. Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints. J Clin Immunol. 1996 Sep;16(5):254–260. doi: 10.1007/BF01541389. [DOI] [PubMed] [Google Scholar]
  44. Stankler L., Bennett F. M. Ataxia telangiectasia. Case report of a benign variant with telangiectasia recurrent infection and low IgA. Br J Dermatol. 1973 Feb;88(2):187–189. [PubMed] [Google Scholar]
  45. Stell R., Bronstein A. M., Plant G. T., Harding A. E. Ataxia telangiectasia: a reappraisal of the ocular motor features and their value in the diagnosis of atypical cases. Mov Disord. 1989;4(4):320–329. doi: 10.1002/mds.870040405. [DOI] [PubMed] [Google Scholar]
  46. Stumm M., Gatti R. A., Reis A., Udar N., Chrzanowska K., Seemanova E., Sperling K., Wegner R. D. The ataxia-telangiectasia-variant genes 1 and 2 are distinct from the ataxia-telangiectasia gene on chromosome 11q23.1. Am J Hum Genet. 1995 Oct;57(4):960–962. [PMC free article] [PubMed] [Google Scholar]
  47. Taylor A. M., Flude E., Laher B., Stacey M., McKay E., Watt J., Green S. H., Harding A. E. Variant forms of ataxia telangiectasia. J Med Genet. 1987 Nov;24(11):669–677. doi: 10.1136/jmg.24.11.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Telatar M., Wang Z., Udar N., Liang T., Bernatowska-Matuszkiewicz E., Lavin M., Shiloh Y., Concannon P., Good R. A., Gatti R. A. Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet. 1996 Jul;59(1):40–44. [PMC free article] [PubMed] [Google Scholar]
  49. Thacker J. Cellular radiosensitivity in ataxia-telangiectasia. Int J Radiat Biol. 1994 Dec;66(6 Suppl):S87–S96. [PubMed] [Google Scholar]
  50. Uziel T., Savitsky K., Platzer M., Ziv Y., Helbitz T., Nehls M., Boehm T., Rosenthal A., Shiloh Y., Rotman G. Genomic Organization of the ATM gene. Genomics. 1996 Apr 15;33(2):317–320. doi: 10.1006/geno.1996.0201. [DOI] [PubMed] [Google Scholar]
  51. Vorechovský I., Luo L., Prudente S., Chessa L., Russo G., Kanariou M., James M., Negrini M., Webster A. D., Hammarström L. Exon-scanning mutation analysis of the ATM gene in patients with ataxia-telangiectasia. Eur J Hum Genet. 1996;4(6):352–355. doi: 10.1159/000472231. [DOI] [PubMed] [Google Scholar]
  52. Watters D., Khanna K. K., Beamish H., Birrell G., Spring K., Kedar P., Gatei M., Stenzel D., Hobson K., Kozlov S. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene. 1997 Apr 24;14(16):1911–1921. doi: 10.1038/sj.onc.1201037. [DOI] [PubMed] [Google Scholar]
  53. Weemaes C. M., Smeets D. F., van der Burgt C. J. Nijmegen Breakage syndrome: a progress report. Int J Radiat Biol. 1994 Dec;66(6 Suppl):S185–S188. [PubMed] [Google Scholar]
  54. Willems P. J., Van Roy B. C., Kleijer W. J., Van der Kraan M., Martin J. J. Atypical clinical presentation of ataxia telangiectasia. Am J Med Genet. 1993 Mar 15;45(6):777–782. doi: 10.1002/ajmg.1320450624. [DOI] [PubMed] [Google Scholar]
  55. Wright J., Teraoka S., Onengut S., Tolun A., Gatti R. A., Ochs H. D., Concannon P. A high frequency of distinct ATM gene mutations in ataxia-telangiectasia. Am J Hum Genet. 1996 Oct;59(4):839–846. [PMC free article] [PubMed] [Google Scholar]
  56. Ying K. L., Decoteau W. E. Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia. Cancer Genet Cytogenet. 1981 Dec;4(4):311–317. doi: 10.1016/0165-4608(81)90027-3. [DOI] [PubMed] [Google Scholar]
  57. Ziv Y., Amiel A., Jaspers N. G., Berkel A. I., Shiloh Y. Ataxia-telangiectasia: a variant with altered in vitro phenotype of fibroblast cells. Mutat Res. 1989 Feb;210(2):211–219. doi: 10.1016/0027-5107(89)90081-x. [DOI] [PubMed] [Google Scholar]
  58. Ziv Y., Bar-Shira A., Jorgensen T. J., Russell P. S., Sartiel A., Shows T. B., Eddy R. L., Buchwald M., Legerski R., Schimke R. T. Human cDNA clones that modify radiomimetic sensitivity of ataxia-telangiectasia (group A) cells. Somat Cell Mol Genet. 1995 Mar;21(2):99–111. doi: 10.1007/BF02255785. [DOI] [PubMed] [Google Scholar]
  59. Ziv Y., Bar-Shira A., Pecker I., Russell P., Jorgensen T. J., Tsarfati I., Shiloh Y. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene. 1997 Jul 10;15(2):159–167. doi: 10.1038/sj.onc.1201319. [DOI] [PubMed] [Google Scholar]
  60. de Graaf A. S., de Jong G., Kleijer W. J. An early-onset recessive cerebellar disorder with distal amyotrophy and, in two patients, gross myoclonia: a probable ataxia telangiectasia variant. Clin Neurol Neurosurg. 1995 Feb;97(1):1–7. doi: 10.1016/0303-8467(94)00048-b. [DOI] [PubMed] [Google Scholar]
  61. de Jonge J., Tijssen C. C. Ataxia telangiectasia in a brother and sister at older age. Clin Neurol Neurosurg. 1988;90(3):279–281. doi: 10.1016/0303-8467(88)90038-8. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES